MACDERMID INC
10-K, 2000-06-26
MISCELLANEOUS CHEMICAL PRODUCTS
Previous: LUTHERAN BROTHERHOOD FAMILY OF FUNDS, NSAR-A, EX-27, 2000-06-26
Next: MACDERMID INC, 10-K, EX-13, 2000-06-26



                                      10-K
                       Annual Report on Form 10-K for 2000
                UNITED STATES SECURITIES AND EXCHANGE COMMISSION
                          WASHINGTON, D.C., 20549-1004
                                    Form 10-K

(X) ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT
OF  1934  [FEE  REQUIRED]  For  the  fiscal  year  ended  March  31,  2000.
                                       OR
( ) TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
ACT  OF  1934  [NO  FEE  REQUIRED].For  the  transition  period  from        to
                       Commission file number       0-2413
                             MACDERMID, INCORPORATED
             (Exact name of Registrant as specified in its Charter)
           Connecticut                        06-0435750
     (State  of  incorporation)     (I.R.S.  Employer  I.D.  No.)
             245 Freight Street, Waterbury, Connecticut  06702-0671
                    (Address of principal executive offices)
        Registrant's Telephone Number, including Area Code (203) 575-5700
        Securities registered pursuant to Section 12(g) of the Act:  NONE
           Securities registered pursuant to Section 12(b) of the Act:
               Title of Class   -   Common Stock Without Par Value
Indicate  by  check mark if disclosure of delinquent filers pursuant to Item 405
of  Regulation  S-K  is  not contained herein, and will not be contained, to the
best  of  registrant's  knowledge, in definitive proxy or information statements
incorporated by reference in Part III of this Form 10-K or any amendment to this
Form  10-K.  (  )
Indicate by check mark whether the Registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the  preceding  12  months  (or  for such shorter period that the Registrant was
required  to  file  such  reports),  and  (2)  has  been  subject  to the filing
requirements  for  the  past  90  days.        Yes  (X)   No  (  )
The  aggregate  market  value  of  the voting stock held by nonaffiliates of the
Registrant  as  of  May  31,  2000  (based  on the closing price on such date as
reported  on  the  New  York  Stock  Exchange)  was  $638,696,000.
The number of shares of Registrant's Common Stock outstanding as of May 31, 2000
was  31,155,921  shares.
                       DOCUMENTS INCORPORATED BY REFERENCE
Portions  of  the  Corporation's  2000  Annual  Report  to  Shareholders  are
incorporated  by reference into Parts I and II hereof and filed as Exhibit 13 to
this  Report.  The  Proxy  Statement  mailed  on  or  about June 26, 2000 to the
Corporation's  stockholders  in connection with the annual meeting scheduled for
July  19,  2000  are  incorporated  herein  by  reference  into Part III hereof.

                                     PART I
Item  1(a)  GENERAL  DEVELOPMENT  OF  BUSINESS
Incorporated  in  Connecticut  in  1922,  MacDermid,  Incorporated  and  its
subsidiaries (collectively, the "Corporation" or "MacDermid") develops, produces
and  markets  a  broad line of specialty chemical products which are used in the
metal  and  plastic  finishing,  electronics,  offshore  lubricants and printing
industries.  MacDermid  offers a line of horizontal processing equipment used in
conjunction with certain of the Corporation's chemical products.  This equipment
is  used  primarily  in the production of printed circuit boards and in chemical
machining.
In  December 1995, MacDermid acquired the assets, subject to certain liabilities
of the Electronics and Printing Division of Hercules Incorporated.  The acquired
business  consists  principally  of  the  manufacture  and  sale  of proprietary
products including photo-resists, used to imprint electrical patterns on circuit
boards, and photo-polymer printing, which reproduces quality graphics on package
printing  and  in-store  displays.  The acquisition, accounted for as a purchase
transaction,  was  financed at closing, through bank borrowings and the issuance
of  preferred stock.  The preferred stock was completely redeemed by utilizing a
portion  of  a  revolving  credit  facility,  in  May  1997.
In  December 1998, MacDermid acquired 95% of the outstanding share capital of W.
Canning,  plc  and  in February 1999, the remaining shares were acquired, by the
Corporation,  through  a  statutory compulsory procedure.  The acquired business
consists  principally  of  the  manufacture  and  sale  of  proprietary products
including  metal and plastic finishing for automotive and other consumer surface
finishing  industries, offshore fluids for oil drilling and exploration, as well
as,  sealants,  adhesives  and  fuel  and  water  additives.  The  acquisition,
accounted  for  as a purchase transaction, was financed through bank borrowings.
In  December  1999,  MacDermid completed a merger with PTI Inc.  The acquisition
was accounted for as a pooling-of-interests transaction.  The Corporation issued
6,999,968  shares  and share equivalents of its common stock in exchange for all
of  the  outstanding  shares  of  PTI Inc.  This business firmly establishes the
Corporation  in the printing industry.  The acquired business consists primarily
of  the  manufacture and sale of proprietary products including offset blankets,
textile  blankets,  printing  plates  and  rubber  based  covers  for industrial
rollers.
The  Corporation's  original  listing application to the New York Stock Exchange
was  accepted  on  February  26, 1998 and since this date its common shares have
traded  on the N.Y.S.E., under the symbol "MRD".  Prior to that, and since 1966,
the  Corporation's  common  shares  had  traded  on  the  NASDAQ  stock  market.
The  Corporation's  Board of Directors authorized a three-for-one stock split on
February  6,  1998,  which  distributed  the  shares  on April 1, 1998 to common
shareholders  of  record  at  the  close  of  business  on  March  16,  1998.
For  a description of the Corporation's business, see Item 1(c) on the following
page.
Item  1(b)  FINANCIAL  INFORMATION  ABOUT  INDUSTRY  SEGMENTS
MacDermid  provides  development,  manufacture, sale and technical service for a
large  variety  of  specialty  chemical  processes  and related equipment in two
reportable industry segments: Advanced Surface Finishes and Graphic Arts.  These
two  segments,  under  which  the Corporation operates on a worldwide basis, are
managed  separately  as each segment has differences in technology and marketing
strategies.

<PAGE>

Item  1(c)  of  this  Report  provides  information concerning the Corporation's
classes  of products and Item 1(d) of this report includes financial information
concerning operations by business segment and by geographic region as well as on
a  consolidated  basis.  Additional  information with respect to the business is
shown  in  the  notes  to  Consolidated  Financial  Statements  portion  of  the
Corporation's 2000 Annual Report to Shareholders, included as Exhibit 13 to this
Form  10-K,  and  is  incorporated  by  reference.

Item  1(c)  NARRATIVE  DESCRIPTION  OF  BUSINESS
(i)  MacDermid  produces  and markets over 5,000 proprietary chemical compounds.
These  proprietary  chemical  compounds  are  used  for cleaning, activating and
polishing,  mechanical  plating,  mechanical  galvanizing,  electro-plating,
phosphatizing  metal  surfaces,  stripping  of  metal and final coating of metal
surfaces,  filtering,  anti-tarnishing,  rust  retarding  and  etching, imaging,
deposition  of  metal,  offshore  lubricants, sealants, adhesives, water and oil
treatments  and  other  chemical  processes.  Research  in  connection  with
proprietary  products  is  conducted  principally  in  the  United  States, with
additional  research  facilities  in  Great  Britain,  France  and  Japan.
In  the  Americas,  the  Corporation markets its entire line of products through
more  than  240 sales and service personnel employed by it and, in certain areas
of  the  United  States, through distributors and manufacturing representatives.
The  Corporation  maintains  chemical  inventories  at more than 25 distribution
points  throughout  the United States.  Typically these facilities are leased or
rented.  In  Canada,  Mexico  and  Brazil  the Corporation both manufactures and
markets certain of its products through wholly owned subsidiaries.  In Vermont a
wholly  owned  subsidiary manufactures and markets equipment in conjunction with
the  proprietary  chemical  business.
In Europe, the Corporation markets its proprietary products through wholly owned
subsidiaries.  European  sales  are  made from inventory stock through more than
360  sales  and  service  representatives  who are employed by the Corporation's
subsidiaries  located  in France, Germany, Great Britain, Italy, Holland, Spain,
Sweden  and  Switzerland.  MacDermid  owns and operates subsidiary manufacturing
facilities  in  Spain,  Great  Britain, Germany and France.  In Germany a wholly
owned  subsidiary  manufactures  and  markets  equipment in conjunction with the
proprietary  chemical  business.
In  the  Asia/Pacific  region,  the Corporation markets its proprietary products
through  wholly  owned subsidiaries in Australia, China/Hong Kong, Japan, Korea,
New  Zealand,  Singapore,  and  Taiwan,  and sales are made through more than 50
sales  and  service  representatives who are employed by local subsidiaries.  In
addition,  sales  are  made  in  India,  Malaysia,  The Philippines and Thailand
directly  or  through  distributors.  MacDermid  owns  and  operates  subsidiary
manufacturing  facilities  in  Taiwan,  Australia  and  New Zealand. In Taiwan a
wholly  owned  subsidiary manufactures and markets equipment in conjunction with
the  proprietary  chemical  business.
In  other foreign markets certain of the Corporation's proprietary chemicals are
manufactured  and  sold  and  in  certain countries in South America, Europe and
Asia,  the  Corporation's products are sold through distributors or manufactured
and  sold  through  licensees.
Chemicals, supplies and equipment manufactured by others and resold by MacDermid
consist  of  basic  chemicals,  automatic  plating conveyors, barrel plating and
pollution  control  equipment,  rectifiers, pumps and filters.  Resale items are
marketed in conjunction with and as an aid to the sale of proprietary chemicals.

<PAGE>
MacDermid's  principal  products  fall  into  the  three  following  classes:
(A)     Chemical  compounds  produced  by the Corporation, most of which are the
result  of  its  own research and development and, therefore, are referred to as
proprietary  products;
(B)     Equipment in support of the chemical business of which approximately 60%
is  manufactured  by  the  Corporation;  and
(C)     Resale  chemicals  and  supplies.

<TABLE>
<CAPTION>

The  following  table  sets  forth  the  classes of MacDermid's products and the
respective  percentage  of total consolidated revenue for each of the last three
fiscal  years:


CLASS OF PRODUCTS      2000   1999   1998
---------------------  -----  -----  -----
<S>                    <C>    <C>    <C>

Proprietary Chemicals    89%    88%    93%
Equipment                 5%     7%     4%
Resale Chemicals and
Supplies                  6%     5%     3%
</TABLE>



 (ii)     MacDermid  uses  in  excess of 1,100 chemicals as raw materials in the
manufacture  of its proprietary products.  With few exceptions, several domestic
sources  of  supply  are  available  for  all  such raw materials and for resale
chemicals,  supplies  and  equipment.  During  fiscal  2000,  there  were  no
significant  difficulties  in obtaining raw materials essential to its business.
(iii)     During fiscal 2000, approximately 20% of MacDermid's proprietary sales
were  derived  from  products  covered  by  patents  owned by the Corporation or
produced  under  patent  license  agreements.  MacDermid  owns  more  than  70
non-expired  U.S. Patents, for which corresponding patents have been obtained or
are  pending  in  most  industrialized  nations,  and  has  more  than 20 patent
applications  pending  in  the  U.S.  The  patents  owned by the Corporation are
important to its business and have varying remaining lives.  Although certain of
the  Corporation's  patents are increasingly more important to its business, the
Corporation  believes that its ability to provide technical and testing services
to its customers and to meet the rapid delivery requirements of its customers is
equally,  if  not  more, important.  In addition, MacDermid has many proprietary
products which are not covered by patents and which make a large contribution to
its total sales.  Further, the Corporation owns a number of domestic and foreign
trade  names and trademarks for which it considers to be of value in identifying
MacDermid  and  its products.  The Corporation neither holds nor has granted any
franchises  or  concessions.
(iv)     No  material  portion  of  the  Corporation's  business  is  seasonal.
(v)     It  is  necessary  to  maintain  finished  goods  inventory at locations
throughout  the  United  States  and  in  the  foreign  countries  in  which the
Corporation  operates so that it may meet the rapid delivery requirements of its
customers.  This  impacts  working  capital  requirements  by  requiring  a
considerable  investment  in  inventories  to  service  its customers.  Customer
payment  terms,  which  vary  by  country,  are  generally  in accord with local
industry  practice.
(vi)     No  major  portion  of  the  Corporation's business is dependent upon a
single  customer  or  a  few customers, the loss of whom would have a materially
adverse  effect  on  its  business.
(vii)     Since  products are taken from inventory stock to ship against current
orders,  there  is  essentially  no  backlog  of  orders  for  the Corporation's
proprietary  chemical  products.  MacDermid  does  not consider the absence of a
backlog  to  be  significant.
(viii)     No  material  portion  of  MacDermid's  business  is  subject  to
re-negotiation  of  profits  or  termination of contracts or subcontracts at the
election  of  the  Government.
(ix)     The Corporation provides a broad line of proprietary chemical compounds
and  supporting  services.  MacDermid  has  many competitors, estimated to be in
excess of 100 in some proprietary product areas.  Some large competitors operate
globally,  as  does  MacDermid,  but most operate locally or regionally.  To the
best  of  the Corporation's knowledge no single competitor competes with all its
proprietary  products.  The Corporation maintains extensive supporting technical
and  testing  services  for  its  customers,  and is continuously developing new
products.  Management  believes  that  the  Corporation's  combined abilities to
manufacture,  sell, service and develop new products and applications enables it
to  compete  successfully  both  locally  and  world-wide.
(x)     MacDermid  spent  approximately $22,548,000, $21,500,000 and $20,618,000
during  fiscal  years  2000,  1999  and  1998,  respectively,  on  research  and
development  activities.  Substantially  all research and development activities
were  sponsored  by  the  Corporation with the greater percentage related to the
development  of  new  products.
(xi)     For  many  years, MacDermid has developed proprietary products designed
to  reduce  the  discharge  of  pollutant  materials  into  the  environment and
eliminate  the  use  of  certain  targeted  raw  materials  while  enhancing the
efficiency  of  customer chemical processes.  For this reason, efforts to comply
with  Federal,  State  and  local provisions, which have been enacted or adopted
regulating  the  discharge  of  materials  into  the environment, may have had a
positive  effect  upon  the  Corporation's  competitive  position.  Capital
expenditures of an estimated $1 million has been spent for environmental control
facilities  annually.  Though  difficult  to  predict,  future spending for this
purpose  is  likely  to  average  roughly  5%  of  the  capital  budget.
(xii)     MacDermid  employed 3,164 and 2,520 full time, regular employees as of
March  31,  2000  and  1999,  respectively.

Item  1(d)  FOREIGN  AND  DOMESTIC  OPERATIONS
MacDermid's  2000  Annual Report to Shareholders, included as Exhibit 13 to this
Form  10-K  and  incorporated by reference, provides information with respect to
geographic  areas  including  operating  information  and  the  effect  upon
shareholders'  equity  of  the  translation  of  foreign  currency  financial
statements.
Item  2  PROPERTIES
Within  the  United  States,  MacDermid  owns  the  following  properties:
In  Connecticut;
At  Waterbury,  a  51,700  square  foot  steel  building,  principally  used for
executive  offices,  marketing  and  corporate support, and a 62,000 square foot
research  and customer service facility, both of which are located on a 5.8 acre
tract.  In  addition,  a  180,000  square foot wood, brick and concrete building
complex  is principally used for manufacturing and warehousing but also includes
some  offices  and  laboratories.  The  complex  is located on a 7.2 acre tract.
Directly across a street from this property, a 31 acre tract of land is held for
possible  future  development.

<PAGE>
In  Delaware;
At Middletown, a concrete and steel building of 85,520 square feet consisting of
factory,  laboratory,  warehouse  and  office facilities located on a 10.97 acre
tract.
At  Wilmington,  a  concrete  and  steel  building  of  26,000  square feet used
principally  as  a technical and administrative services center located on a 3.8
acre  tract.  Also  on  this  site  is  an 18,000 square foot concrete and steel
building  which  is  used  for  research  activities  and  may  also be used for
manufacturing  expansion  should  the  need  arise.
In  Michigan;
At  Ferndale,  a  steel  frame  and  steel  sided building of 75,000 square feet
consisting principally of factory, warehouse and office facilities, located on a
6.25  acre  tract.
At  New  Hudson,  a  steel and brick single story building of 15,000 square feet
consisting  of  research  laboratories  and  offices  located on a 7 acre tract.
In  Illinois;
At  Waukeegan,  a  masonry building of 25,000 square feet consisting of factory,
laboratory,  warehouse  and  office  facilities  located on a 1 acre tract.  In,
addition,  there  are  two  adjacent tracts of land totaling 1.3 acres which are
being  held  for  sale or lease but which could be used for manufacturing should
the  need  arise.
In  Massachusetts;
At  Adams,  a  brick  and  wood  building  of  130,000 square feet consisting of
factory,  warehouse  and  office  facilities  located  on  an  8  acre  tract.
In  Tennessee;
At  Morristown,  a brick and steel building of 250,000 square feet consisting of
factory,  warehouse  and  office  facilities  located  on  a  23.75  acre tract.
In  Georgia;
At  Atlanta,  a  brick  and  steel  building of 65,000 square feet consisting of
research  laboratories  and  sales  offices  located  on  a  5.75  acre  tract.
In  California;
At San Marcos, a concrete building of 235,000 square feet consisting of factory,
warehouse,  research laboratories and office facilities located on an 11.75 acre
tract.
The  Corporation  also owns property in Vernon, Connecticut, which is being held
for  sale  or  lease  but  which could be used for manufacturing should the need
arise.
Outside  the  United  States,  the  Corporation  owns  additional  properties as
follows:
In  Spain;
At  Barcelona,  a  steel  and  brick  building of 31,000 square feet of factory,
warehouse,  laboratory  and  office  space.
In  England;
At  Telford,  two  brick,  concrete and steel buildings, connected by a walkway,
containing a total of 43,000 square feet of manufacturing, warehouse, laboratory
and  office  space.
At  Birmingham, two brick, concrete and steel buildings, connected by a walkway,
containing  a  total  of  110,000  square  feet  of  manufacturing,  warehouse,
laboratory  and office space and at a separate location nearby a brick, concrete
and  steel building of 120,000 square feet of manufacturing and warehouse space.
At  Sheffield,  a  steel and concrete building of 4,500 square feet of warehouse
and  laboratory  space.
At  Wigan,  a  brick,  concrete  and  steel  building  of  65,000 square feet of
manufacturing,  warehouse  and  office  space.
In  France;
At  Villemeux,  a  steel  and  concrete  building  of  50,000  square  feet  of
manufacturing,  warehouse  and  office  space.
At  Eure,  a steel and concrete building of 41,000 square feet of manufacturing,
warehouse,  laboratory  and  office  space.
At  Cernay,  a  steel  and  concrete building of 235,000 square feet of factory,
warehouse  and  office  space.
At  Steinbach,  a  wood and brick building of 150,000 square feet of factory and
warehouse.
At  Evreux,  a  steel  building  of 68,000 square feet of factory and warehouse.
In  Germany;
At  Dusseldorf,  a  steel  and  concrete  building  of  17,000  square  feet for
manufacturing.
At Zulpich, a steel and concrete building of 12,000 square feet of manufacturing
and  office  space.
In  the  Republic  of  China;
At Hsin Chu, Taiwan, two buildings of reinforced concrete totaling 30,000 square
feet,  located  on  a  1.8  acre tract, used for factory, warehouse and offices.
At  Hong Kong, 30,000 square feet office, labs and warehouse space in a concrete
block  building.
At  Panyu,  three  buildings of reinforced concrete totaling 64,000 square feet,
located  on  a  4  acre  tract,  used  for  factory,  warehouse  and  offices.
The  Corporation  also owns property at Birmingham, Wigan and Droitwich, England
which  is  presently  leased,  as  well as at Rosay Par Prouais, France which is
being  held  for  sale  or  lease.
In  addition,  MacDermid  leases office, laboratory, warehouse and manufacturing
facilities  as  needed.  During the year, such additional facilities were leased
in  California,  Massachusetts,  Michigan,  North  Carolina,  New  Jersey, Rhode
Island,  Texas,  Vermont,  Washington,  Canada,  Mexico, Holland, Italy, France,
Germany,  Sweden,  Korea,  Australia,  Japan, Singapore, China and several other
foreign  countries.  All  owned  and leased facilities are in good condition and
are  of  adequate  size  for  present  business  volume.
Item  3     LEGAL  PROCEEDINGS
Legal  proceedings  are  contained  in  MacDermid's  2000  Annual  Report  to
Shareholders  included  as  Exhibit  13  to  this  form  10K and incorporated by
reference.
Item  4  SUBMISSION  OF  MATTERS  TO  A  VOTE  OF  SECURITY  HOLDERS
There  were no matters submitted to a vote of the Corporation's security holders
during  the  fourth  quarter  of  fiscal  2000.

<PAGE>
Item  4A  EXECUTIVE  OFFICERS  OF  MACDERMID
The names, offices and ages (as of March 31, 2000) of all the executive officers
of MacDermid, each of whom has been employed in his/her respective office(s) for
more  than  five  years,  except  as  noted  are  as  follows:
Daniel  H.  Leever,  age  51,  has been Board Chairman since July 1998 and Chief
Executive  Officer  since  1990.

R.  Nelson Griebel, age 50, has been President and Chief Operating Officer since
February  1999.  Previously,  and  since 1977 he was with BankBoston, serving as
Executive  Vice  President  and as Regional President of Connecticut and western
Massachusetts  operations.

Stephen  Largan,  age  32, has been Vice President, Finance since February 1999.
Previously,  and  since  1993  he  was  with a subsidiary of Ford Motor Company,
serving  as  Director  of  Finance.

Gregory  M.  Bolingbroke,  age  50,  has  been  Corporate Controller since 1995.

John  L.  Cordani,  age  37,  Mr.  Cordani  resigned  effective  May  19,  2000.
Previously,  he  was  Corporate  Secretary  since 1995 and General Counsel since
1993.

Mary  Anne  B. Tillona, age 42, has been Corporate Secretary since June 2000 and
Deputy  General  Counsel  since  April 2000.  Previously, and since 1995 she was
Corporate  Counsel  for  Dexter  Corporation.

<PAGE>

          PART  II
Item  5     MARKET  FOR  MACDERMID'S  COMMON  STOCK  AND RELATED SECURITY HOLDER
MATTERS
Information  with  respect to the market for MacDermid's Common Stock, dividends
paid  and  other  related  information is contained in its 2000 Annual Report to
Shareholders  included  as  Exhibit  13  to  this  form 10-K and incorporated by
reference.
Item  6     SELECTED  FINANCIAL  DATA
The selected financial data (Five-Year Summary) is contained in MacDermid's 2000
Annual  Report  to  Shareholders  included  as  Exhibit 13 to this Form 10-K and
incorporated  by  reference.
Item  7     MANAGEMENT'S  DISCUSSION  AND  ANALYSIS  OF  FINANCIAL CONDITION AND
RESULTS  OF  OPERATIONS
Management's  Discussion  and  Analysis  of  Financial  Condition and Results of
Operations  is  contained  in  MacDermid's  2000  Annual  Report to Shareholders
included  as  Exhibit  13  to  this  Form  10-K  and  incorporated by reference.
Item  7(a)  QUANTITATIVE  AND  QUALITATIVE  DISCLOSURES  ABOUT  MARKET  RISK
The  Corporation  is exposed to market risk in the normal course of its business
operations due to its operations in different foreign currencies and its ongoing
investing  and  financing  activities. The risk of loss can be assessed from the
perspective  of  adverse changes in fair values, cash flows and future earnings.
The Corporation has established policies and procedures governing its management
of  market risks and the use of financial instruments to manage exposure to such
risks.
The  Corporation  is  exposed  to  interest  rate risk primarily from its credit
facility  which  is  based  upon various floating rates.  At March 31, 2000, the
Corporation  had  entered  into  interest  rate swaps with an aggregate notional
amount  that  approximates  one-third  of  its  borrowings.  The  resulting
weighted-average  fixed  interest  rate  is 6.2%.  Based upon expected levels of
borrowing  under  this  facility  in  2001, an increase in interest rates of 100
basis  points  would  result in an incremental $2.8 million interest expense and
would  not  have  a  material  adverse  affect on the Corporation's consolidated
financial  position,  results  of  operations  or  cash  flows.
The  Corporation  operates manufacturing facilities in eight countries and sells
products in over 25 countries.  Approximately 45% of the Corporation's sales are
denominated  in  currencies  other  than  the  US  Dollar.  Historically,  the
Corporation  returns  slightly  less  than  10%  on  sales  and foreign exchange
fluctuations  have  not  had  any  significantly  measurable effect on earnings.
Furthermore,  those  earnings are generally reinvested locally and the impact on
operating  cash  flows  has  been  less  than $3.5 million annually.  Management
continually  reviews the balance between foreign currency denominated assets and
liabilities  in order to minimize the exposure to foreign exchange fluctuations.
The  Corporation  does  not  enter into any derivative financial instruments for
trading  purposes,  nor  does  it  enter into any foreign currency hedging.  The
Corporation  has  certain supply agreements for quantities but has chosen not to
enter  into  any  price  hedging with its suppliers for commodities.  Additional
information  about market risk is contained in MacDermid's 2000 Annual Report to
Shareholders  included  as  Exhibit  13  to  this  Form 10-K and incorporated by
reference.

Item  8     FINANCIAL  STATEMENTS  AND  SUPPLEMENTARY  DATA
The  consolidated  financial  statements,  including  the  notes thereto, of the
Corporation  are  contained  in  MacDermid's  2000 Annual Report to Shareholders
included  as  Exhibit  13  to  this  Form  10-K  and  incorporated by reference.
Additional  financial  information  is  contained in the Financial Data Schedule
appearing  as  Exhibit  27  to  this  report.
Item  9  DISAGREEMENTS  ON  ACCOUNTING  AND  FINANCIAL  DISCLOSURE
None.

<PAGE>
PART  III
Item  10  DIRECTORS  AND  OFFICERS
The discussion of "Election of Directors" and a portion of the discussion in the
section,  "Interest  of Management and Others in Certain Transactions and Family
Relationships"  contained in MacDermid's Proxy Statement dated June 19, 2000 are
incorporated  herein  by  reference  thereto.  Officers  of  the Corporation are
listed  in  Item  4A,  above.
Item  11  EXECUTIVE  COMPENSATION
The  discussion  of  "Executive  Compensation"  contained  in  MacDermid's Proxy
Statement  dated  June  19,  2000  is  incorporated herein by reference thereto.
Item  12     SECURITY  OWNERSHIP  OF  CERTAIN  BENEFICIAL  OWNERS AND MANAGEMENT
Information  with respect to the security ownership of certain beneficial owners
and  management  contained in MacDermid's Proxy Statement dated June 19, 2000 is
incorporated  herein  by  reference  thereto.
Item  13     CERTAIN  RELATIONSHIPS  AND  RELATED  TRANSACTIONS  AND  FAMILY
RELATIONSHIPS
The discussion of "Interest of Management and Others in Certain Transactions and
Family  Relationships"  contained  in MacDermid's Proxy Statement dated June 19,
2000  is  incorporated  herein  by  reference  thereto.

<PAGE>
PART  IV

Item  14     EXHIBITS,  FINANCIAL  STATEMENT  SCHEDULES  AND  REPORTS  ON
FORM  8-K
(a)     (1)     Financial  Statements
The  consolidated financial statements and report thereon of KPMG LLP, dated May
12,  2000  are  contained  in  MacDermid's  2000  Annual  Report to Shareholders
included  as  Exhibit 13 to this Form 10-K and incorporated herein by reference.
Additional  financial  information  is  contained in the Financial Data Schedule
included  as  Exhibit  27  to  this  report.
     (2)     Financial  Statement  Schedules
The  following  schedules  are filed as part of this Annual Report on Form 10-K.
This  supplementary  financial  data  should  be  read  in  conjunction with the
consolidated  financial  statements  and  comments  thereto  referred  to above.
Schedules  not included with this supplementary financial data have been omitted
because  they  are not applicable, are immaterial or the required information is
included  in  the  consolidated  financial  statements  or  related  notes  to
consolidated  financial  statements.
Schedule  II  -  Valuation  and Qualifying Accounts and Reserves is contained in
MacDermid's  2000  Annual  Report to Shareholders included as Exhibit 13 to this
Form  10-K  and  incorporated  herein  by  reference

Auditors'  Report  on  Supporting  Schedule
     (3)     Exhibits
An index to the exhibits filed or incorporated by reference immediately precedes
such  exhibits.
     (b)  Reports  on  Form  8-K
The  Corporation  filed  a report on Form 8-K, dated January 3, 2000, during the
fourth quarter of fiscal 2000.  This report contains information with respect to
a  press  release announcing the consummation of the merger on December 29, 1999
between  the  Corporation  and  PTI  Inc.  upon  approval from the Federal Trade
Commission  and  is  incorporated  by  reference.
The Corporation filed a report on Form 8-K, dated May 15, 2000, during the first
quarter  of  fiscal  2001.  This  report  contains information with respect to a
press  release  announcing  the  Corporation's  fiscal year 2000 earnings and is
incorporated  by  reference.




                                   SIGNATURES
Pursuant  to  the requirements of Section 13 or 15(d) of the Securities Exchange
Act  of  1934, the Registrant has duly caused this Annual Report on Form 10-K to
be  signed  on  its  behalf  by  the  undersigned,  thereunto  duly  authorized.
                             MACDERMID, INCORPORATED
                                  (Registrant)
                              Dated:  June 26, 2000
By     /s/  Daniel  H.  Leever     By    /s/  Gregory  M.  Bolingbroke
        Daniel  H.  Leever             Gregory  M.  Bolingbroke
        Director,  Chairman  and             Corporate  Controller  and
        Chief  Executive  Officer             Chief  Accountant


Daniel H. Leever, pursuant to powers of attorney which are being filed with this
Annual Report on Form 10-K, has signed below on May 12, 2000 as attorney-in-fact
for  the  following  directors  of  the  Registrant:
            Donald  G.  Ogilvie     -      Thomas  W.  Smith     -      James C.
Smith
                           -     R. Nelson Griebel     -     Joseph M. Silvestri
                              /s/ Daniel H. Leever
                                Daniel H. Leever

<PAGE>
EXHIBIT  INDEX
                          2000 FORM 10-K ANNUAL REPORT
Exhibit
No.
 3.1  Restated Certificate of Incorporation, MacDermid,
      Incorporated, amended as of December 1, 1997.
      Exhibit 19 to September 30, 1991
      Form 10-Q Quarterly Report is incorporated
      by reference herein.                                    By reference
 3.2  By-Laws, amended as of February, 1997.
      Exhibit 3b to 1985
      Form 10-K Annual Report is incorporated
      by reference herein.                                    By reference
 4.1  Credit Agreement, amended and restated,
      dated as of November 11, 1999, among
      MacDermid, Incorporated, the Banks
      signatory thereto and Bank of America,
      as Agent, letter of credit issuing bank and
      swing line lender is incorporated by reference herein.  By reference
10.1  MacDermid, Incorporated Special Stock
      Purchase Plan, amended as of November 1, 1992.
      Exhibit 10 to 1993 Form 10-K Annual
      Report is incorporated by reference herein.             By reference
10.2  MacDermid, Incorporated 1995 Equity
      Incentive Plan Exhibit 10.2 to 1996
      Form 10-K Annual Report is Incorporated
      by reference herein.                                    By reference
10.3  MacDermid, Incorporated 1998 Equity
      Incentive Plan Exhibit 10.3 to 1999
      Form 10-K Annual Report is Incorporated
      by reference herein.                                    By reference
11    Computation of per share earnings.
      Note 7 to MacDermid's 2000 Annual
      Report to Stockholders                                  Attached
13    Portions of MacDermid's 2000
      Annual Report to Stockholders
      as required by Item 8                                   Attached
21    Subsidiaries of MacDermid, Incorporated                 Attached
23    Independent Auditors' Consent                           Attached
24    Power of Attorney                                       Attached
27    Financial Data Schedule                                 Attached


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission